Clinical Trials Browser

NETWORK × Triple Negative Breast Neoplasms × Cyclophosphamide × Clear all

NCT07297667 2026-05-12

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Phase 1 Not yet recruiting

BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

NCT00022516 2016-09-16

22-00

Phase 3 Completed

1,086 enrolled 10 charts

Breast Neoplasms, Triple Negative Breast Neoplasms